A biobank for diabetes research in Hong Kong
An Integrated Trans-omics Approach to Diabetic Cardio-renal Complications: From Novel Discoveries to Personalized Medicine Substudy 2: The Hong Kong Diabetes Biobank
This study is collecting health and genetic information from people with diabetes in Hong Kong to see if it can help find ways to predict and prevent complications like kidney disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 48000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Shatin) |
| Trial ID | NCT05282680 on ClinicalTrials.gov |
What this trial studies
The Hong Kong Diabetes Biobank aims to collect comprehensive clinical and genetic data from individuals with diabetes across various centers in Hong Kong. Participants will undergo routine assessments for diabetes complications, including clinical evaluations and collection of biological samples for genomic and biomarker studies. This observational study seeks to identify genetic factors associated with diabetic complications, particularly diabetic kidney disease, to improve prediction and prevention strategies. Informed consent will be obtained from all participants, ensuring ethical standards are met.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals with a known diagnosis of diabetes, regardless of type.
Not a fit: Patients who are unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this biobank could lead to improved prediction and prevention of diabetes and its complications, ultimately enhancing patient outcomes.
How similar studies have performed: Other studies have shown success in utilizing biobanks for genetic research in diabetes, indicating a promising approach for this initiative.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * subjects with known diabetes Exclusion Criteria: * subjects not capable of giving written informed consent
Where this trial is running
Shatin
- Prince of Wales Hospital — Shatin, Hong Kong (Recruiting)
Study contacts
- Principal investigator: Ronald C Ma, FRCP — Department of Medicine and Therapeutics, The Chinese University of Hong Kong
- Study coordinator: Ronalld C Ma, FRCP
- Email: rcwma@cuhk.edu.hk
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.